It’s the leading frontier of medicine: Clinical research, also known as clinical trials, is a way for physicians and researchers to test new approaches to treatments and potentially improve a patient’s quality of life.
The Stormont Vail Health Clinical Research team is currently supporting more than 100 active clinical research trials, partnering with medical teams nationwide and around the world. It’s part of our commitment to develop and refine new medical treatments and therapies that can enhance patient care and well-being.
Bringing Leading-Edge Clinical Research to Kansas
We have more than 50 enrolling research opportunities and offer clinical trials in various therapeutic areas, including:
- Digestive health
- General medicine
- Alzheimer’s and dementia
- Allergy and pulmonology
We have a large group of physicians, advanced practice providers and other research professionals involved in clinical trials. They often collaborate with national and global research leaders from the National Institutes of Health, the National Cancer Institute, major pharmaceutical research companies, and other leading research organizations.
New Treatments, New Hope
If you are interested in clinical trials at Stormont Vail, you can ask your health care provider for more information, or you can contact us directly at (785) 368-0744.
We will assess your eligibility and review with you what the study involves, including potential risks. The clinical trials are all voluntary, so we will require your consent beforehand.
Please note that before a new treatment can be used in a clinical trial, it has been under study by scientific and medical professionals for many years. Also, clinical trials must be approved by an Institutional Review Board — a board made up of independent members who ensure the trial is ethical, offering potential benefits to patients.
Patient participation in research helps accelerate the advancement of new treatments and therapies. Here are some of the clinical trials in which we’re involved:
Treatments for Eosinophilic Esophagitis (EoE)
Cotton O’Neil gastroenterologists are exploring new ways to treat eosinophilic esophagitis (EoE) — a digestive issue whose symptoms include swallowing difficulties and chest pain.
EoE occurs when an eosinophils, a type of white blood cell, multiplies and builds up in the lining of the esophagus in reaction to things such as food.
EoE has been identified only in the past two decades and has been increasingly diagnosed in patients with gastric symptoms. Scientists theorize that environmental factors may be contributing to the uptick in cases.
Damage to the esophagus from EoE can be permanent. There are currently no FDA-approved treatments. Stormont Vail has two active clinical research trials evaluating topical steroids that are delivered in novel ways to the lining of the esophagus.
For more information about our clinical trials on EoE, contact the Clinical Research Center at (785) 368-0744.
The Race to Slow and Prevent Alzheimer’s Disease
The Cotton O’Neil Clinical Research Center has active trials for patients with moderate Alzheimer’s disease and for those who have early symptoms or very early Alzheimer’s.
We conduct baseline memory screening assessments and determine whether patients might be in the early stages of the disease. We are searching for new medical treatments as the number of patients with Alzheimer’s disease is increasing significantly in Kansas.
Currently, there are more than 300 promising treatments in clinical trials. Clinical trials are designed to evaluate whether these new treatments are effective in preventing or delaying the disease progression.
For a free memory screening or more information about clinical trials on Alzheimer’s disease, contact the Clinical Research Center at (785) 368-0744.
Large Cancer Clinical Research Panel
The Cotton O’Neil Cancer Center provides care to more than 1,000 newly diagnosed cancer and hematology patients each year. Many of them seek participation in a clinical research trial. Our research team has been the first to enroll cancer patients in trials, leading the nation in offering access to innovative potential treatments and helping cancer patients access the best research options from the center of the county.
There have been many important advances in cancer treatment – immunotherapy, personalized medicine, vaccines and breakthrough medications – and we’ve made a contribution to many of them. The Clinical Research Center maintains a panel of more than 50 active research trials in this therapeutic area.